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Abstract
Background: Stem cell protein Piwil1 functions as an oncogene in various tumor types. However, the exact
function and mechanism of Piwil1 in endometrial cancer remains unclear.
Methods: The expression of Piwil1 and its relationships with clinicopathological factors were investigated using
immunohistochemistry. Up- or down-regulation of Piwil1 were achieved by stable or transient transfection with
plasmids or short hairpin RNA (shRNA). Effects of Piwil1 on cancer cells viability, invasion and migration were
evaluated by MTT, plate colony formation, transwell assay and nude mouse tumor xenograft assay. The stem-like
properties of endometrial cancer cells was detected by spheroid formation assay. Effects of Piwil1 on expression
levels of target genes were detected by qRT-PCR, western blotting and Immunofluorescence.
Results: Compared with atypical hyperplasia and normal tissues, Piwil1 was much higher in endometrial carcinoma
tissues. We found that Piwil1 expression was significantly correlated with FIGO stage, lymphovascular space
involvement, lymph node metastasis and level of myometrial invasion. Overexpression of Piwil1 functioned to
maintain stem-like characteristics, including enhancing tumor cell viability, migration, invasion and sphere-forming
activity. Conversely, Piwil1 knockdown inhibited cell viability, migration, invasion, sphere-forming activity in vitro
and tumor formation in xenograft model in vivo. Furthermore, study of the expression of epithelial and
mesenchymal markers showed that Piwil1 was responsible for an EMT-like phenotype associated with an increase
in mesenchymal markers and suppression of E-cadherin. Moreover, Piwil1 augmented expression levels of CD44
and ALDH1 expression, two known endometrial CSC markers, as well as other stemness-associated genes.
Conclusions: Our results suggested that stem cell protein Piwil1 play important roles in regulating EMT and the
acquisition of stem-like properties of endometrial cancer cells. Therefore, it indicated that Piwil1 may represent a
promising target for developing a novel treatment strategy for endometrial cancer.
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Background
Cancer of the corpus uteri (commonly called endomet-
rial cancer) is one of the most common malignancies of
the reproductive system. In the United States, approxi-
mately 52,630 new cases will be diagnosed in 2014 and
8590 deaths are expected [1]. Therefore, it is critical to
better understand the molecular mechanisms of endo-
metrial cancer.
Cancer stem cells (CSCs) are defined by their ability
to seed new tumors and are proposed to be the
cancer-initiating cells responsible for carcinogenesis
[2, 3]. To date, CSCs have been isolated from various
human cancer tissues [4, 5]. Emerging evidence indi-
cates that a population of CSCs may be involved in
endometrial carcinoma carcinogenesis [6, 7]. The
epithelial-mesenchymal transition (EMT) is a well-
described process whereby epithelial cells lose their
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polarity and cell-cell contacts, undergoing a dramatic
remodeling of the cytoskeleton and acquiring a migra-
tory phenotype. Recent studies have highlighted a link
between EMT and the induction of the stem cell-like
properties of cancer cells in solid tumors [8–10].
The Piwil1 gene is a member of the Piwi gene family,
which represent the first class of evolutionarily conserved
genes known to be required for stem cell self-renewal and
division [11, 12]. Piwil1 has been found to be frequently
overexpressed in various tumor types, including gastric
cancer, breast cancer and endometrial cancer [13, 14]. Pre-
vious studies have demonstrated that Piwil1 played a key
role in enhancing tumor malignant behavior including
proliferation [13, 15] and invasion [16], as well as the po-
tential importance of Piwil1 expression as a marker of
poor prognosis in soft-tissue sarcoma and ductal adeno-
carcinoma of the pancreas [17, 18].
On the basis of these findings, we believe that both or
partly of Piwil1 and EMT are involved in the acquisition
of stem-like properties, with the hope that such associa-
tions might provide insights into the causal function of
Piwil1 in endometrial carcinogenesis.
Methods
Ethics statement
The study was approved by the Human Investigation
Ethics Committee of Shanghai First People’s Hospital
Affiliated to Shanghai Jiao Tong University. The samples
of endometrial carcinoma and normal endometrial tis-
sues were collected after written informed consent from
the patients. Animal research was carried out in strict
accordance with the Guide for the Care and Use of
Laboratory Animals. The procedures were approved
by the Department of Laboratory Animal Science at
Shanghai Jiao Tong University School of Medicine.
All efforts were made to minimize suffering.
Tissue specimens
Tissue samples for immunohistochemistry and real-time
quantity PCR (RT-qPCR) were obtained at Shanghai
First People’s Hospital Affiliated to Shanghai Jiao Tong
University from 2011 to 2013. The stages and histo-
logical grades of these tumors were established accord-
ing to the criteria of the Federation International of
Gynecology and Obstetrics (FIGO) surgical staging
system (2009) [19]. None of the patients underwent hor-
mone therapy, radiotherapy, or chemotherapy prior to
surgery.
Cell culture
Human endometrial cancer cell lines including Ishikawa
and HEC-1B were obtained from the Chinese Academy of
Sciences Committee Type Culture Collection (Shanghai,
China, Additional file 3). According to the provider’s
instructions, cells were cultured at 37 °C in a humidified
atmosphere containing 5 % CO2 in Dulbecco’s modified
Eagle’s medium (DMEM)/F12 (Gibco, Life Technologies,
Auckland, New Zealand) supplemented with 10 % fetal
bovine serum (Gibco, Carlsbad, CA, USA).
Ishikawa cell line is a human endometrial adenocarcin-
oma cell line which contains estrogen and progesterone
receptors [20]. HEC-1B cell line is a human endometrial
adenocarcinoma cell line which has a low baseline level
of estrogen and progesterone receptors [21].
Immunohistochemistry
Tissue immunohistochemistry was performed by the
3,3'-diaminobenzidine (DAB) method with a heat-induced
antigen retrieval step. Briefly, slides were incubated with
rabbit polyclonal anti-Piwil1 (1:100, ab105393, Abcam),
rabbit monoclonal anti-E-cadherin (1:400, #3195, CST),
rabbit monoclonal anti- Vimentin (1:100, #5741, CST),
rabbit monoclonal anti-CD44 (1:100, ab51037, Abcam),
rabbit monoclonal anti-ALDH1 (1:100, ab52492, Abcam),
rabbit monoclonal anti-ki67 (1:100, ab16667, Abcam) and
rabbit monoclonal anti-PCNA (1:100, ab92552, Abcam)
overnight at 4 °C and then incubated with horseradish
peroxidase (HRP)-linked anti-rabbit or anti-mouse sec-
ondary antibody (Boster) at room temperature for 30 min
followed by chromagen detection with DAB (Boster)
and hematoxylin (Boster) counterstaining. Isotype control
antibodies was used as negative control.
Two independent pathologists, who were blinded to the
clinical and pathological data, evaluated the specimens.
Sections were evaluated according to semi quantitative
immunoreactivity scores. We separately scored for the
percentage of positive staining (0 = negative, 1 = 25 %, 2 =
25–50 %, 3 = 50–75 % and 4 = 75 %) and the staining in-
tensity (0 = none, 1 = weak, 2 =moderate, and 3 = strong).
For each specimen, the summation of the two above gave
the final score.
Total RNA extraction and real-time RT-PCR
Total RNA was extracted from tissues and cell lines
using Trizol (Invitrogen) and cDNA was prepared using
the reverse transcriptase kit (TaKaRa) according to the
manufacturer’s instructions. The cDNA was analyzed by
real-time PCR using SYBR Premix Ex Taq (TaKaRa) in
an Eppendorf Mastercycler realplex. A housekeeping
gene, GAPDH, was used as an internal control. Data was
calculated using the 2-△△Ct formula. Primers sequences
are shown in Additional file 1: Table S1.
Western blotting
Cells were lysed in lysis buffer (Beyotime) for 30 min at
4 °C. Total proteins were fractionated by SDS–PAGE
and transferred onto PVDF membranes (Millipore). The
membranes were then incubated with primary antibodies
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against Piwil1 (1:1000, ab105393, Abcam), E-cadherin
(1:1000, #3195, CST), N-cadherin (1:1000, #13116, CST),
Vimentin (1:1000, #5741, CST), CD44 (1:5000, ab51037,
Abcam), CD133 (1:1000, 18470-1-AP, ProteinTech) and
ALDH1 (1:1000, ab52492, Abcam) at 4 °C overnight,
followed by incubation with peroxidase-linked secondary
antibody (1:10000, 112-005-003, Jackson ImmunoRe-
search). The probed proteins were detected by enhanced
chemiluminescent reagents (Thermo). GAPDH (1:2000,
#5174, CST) was used as an internal control.
Immunofluorescence
Cells were cultured on glass coverslips for 24 h and then
fixed in 4 % paraformaldehyde. They were permeabilized
with 0.1 % Triton X-100. After blocking in 5 % bovine
serum albumin for 1 h at room temperature, cells were
incubated with primary antibodies as follows: Piwil1
(1:50, ab105393, Abcam), E-cadherin (1:200, #3195, CST),
Vimentin (1:100, #5741, CST), CD44 (1:100, ab51037,
Abcam), CD133 (1:100, 18470-1-AP, ProteinTech) and
ALDH1 (1:1000, ab52492, Abcam) overnight at 4 °C. Next,
cells were incubated with Alexa Fluor 647 or rhoda-
mine (TRITC)-conjugated secondary antibodies (1:200,
Jackson ImmunoResearch) for 1 h. Nuclei were visual-
ized by counterstaining with 496-diamidino-2-pheny-
lindole (DAPI). Samples were analyzed using a Leica
TCS SP8 confocal microscope (Leica Microsystems).
Isotype control antibodies was used as negative control.
Stable transfection
HEC-1B cells were transfected with Piwil1 expression
plasmids (exPiwil1, Genepharma, Shanghai, China) or
control plasmids (pEGFP-N1, empty vector, EV, Gene-
pharma) by LipofectamineTM 2000 (Invitrogen) according
to the manufacturer’s protocol. Stable overexpression
clones (HEC-1BexPiwil1 and HEC-1BEV cells) were selected
in the presence of 1 mg/ml G418 (Gibco) and then propa-
gated in the presence of 0.5 mg/ml G418.
Ishikawa cells were transfected with shRNA against
Piwil1 (shPiwil1, Genepharma) (sense: 5’-AGTCAGC
AACCTGGTTATA-3’; antisense: 5’- TATAACCAGGTT
GCTGACTGG -3’) or shRNA against nontarget (NT,
Genepharma) by Lipofectamine™ 2000. Stable knock-
down clones (IshikawaEV and IshikawashPiwil1 cells) were
selected in the presence of 0.5 μg/ml puromycin (Sigma;
St. Louis, MO, USA) and maintained with 0.3 μg/ml.
Transfection efficiency was confirmed by RT-qPCR and
western blot.
MTT and colony-formation assays
Cells and transfected cells (3 × 103 cells/well) were plated
in 96-well plates. Then, 20 μl of 3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyl-tetrazolium bromide (MTT, 5 mg/ml;
Sigma) was added to each well and then incubated at
37 °C for 4 h. Absorbance values were then measured at
490 nm using a microplate reader (Bio-Red). For colony
formation assay, 200 cells/well were seeded into 6-well
plates. When clearly identifiable cell clones had formed,
the colonies were fixed with methanol and stained with
0.5 % crystal violet. All experiments were repeated at
least three times.
Cell migration and invasion assays
Cell lines were suspended in serum-free medium and
plated at a density of 1 × 105 cells/well (for the migration
assay) or 2 × 105 cells/well (for the invasion assay) in
6.5 mm transwell chambers equipped with 8.0 μm pore-
size polycarbonate membranes without or with matrigel
coating (BD Biosciences). Complete medium (600 μl)
was added to the lower chamber. After incubation for
24 h (migration assay) or 48 h (invasion assay), cells
were fixed in 4 % paraformaldehyde and stained with
crystal violet. Then cells that migrated to the basal side
of the membrane were counted at 200× magnification.
The migration and invasion assays were repeated at least
three times.
Spheroid formation
Cells (5 × 103) were plated on non-adherent 6-well
culture plates (coated with a 10 % polyHEMA (Sigma)
for 4 h and dried for 3 days at 37 °C). After plating,
cells were incubated in a serum-free medium consist-
ing of DMEM/F12 supplemented with 20 ng/ml of
EGF, 10 ng/ml of bFGF, and 2 % B27 (all from Sigma
and Gibco). The number of spheroids per well was
counted after 5 days under light microscopy at a 200-
fold magnification. The experiments were repeated at
least three times.
Nude mouse tumor xenograft assay
Athymic female nude mice (BALB/c, 4 to 6 week old,
n = 5 per group) were obtained from Shanghai Life
Science Institute (Slac Laboratory Animal Co., Ltd,
Shanghai, China). IshikawashPiwil1 or IshikawaNT cells
were injected subcutaneously into the flank of each
mouse at a density of 1 × 107 cells to establish a
mouse model bearing endometrial cancer. The growth
of tumors was monitored throughout the experiment
and tumor size was measured with calipers every
4 days and the tumor volume was calculated as
(Rmax) × (R2 min)/2. Four weeks after injection, mice
were euthanized, tumors were removed carefully, and
the weight and volume of tumors were measured.
Statistical analysis
All data analyses were performed using the software
package SPSS v. 18 (SPSS Inc., Chicago, IL, USA). Values
were expressed as mean ± the standard deviation and
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analyzed with the Student’s t-test or Mann–Whitney
U test. Significant differences were indicated for P
values < 0.05.
Results
Piwil1 was overexpressed in endometrial cancer tissues
We examined 18 endometrial cancer tissues (15 endo-
metrioid and 3 serous) and 10 normal endometrial tis-
sues (6 proliferative and 4 secretory) through RT–qPCR.
We observed a striking pattern of Piwil1 overexpression
in endometrial cancer tissues compared to normal endo-
metrial tissues (**P < 0.01, Fig. 1a).
To confirm this result at the protein level, we exam-
ined the protein expression of Piwil1 in clinical samples
using immunohistochemistry. Piwil1 immunostaining
was absent or weak in normal endometrial tissues but
moderate-to-strong in endometrial atypical hyperplasia
and endometrial cancer tissues (Fig. 1b). Consistent with
our RT-qPCR analysis, the protein expression of Piwil1
was also significantly higher in endometrial atypical
hyperplasia (IS = 2.9, ***P < 0.001) and endometrial can-
cer tissues (IS = 5.0, ***P < 0.001) compared with normal
endometrial tissues (IS = 1.5, Fig. 1c).
We further investigated the association between Piwil1
expression and clinicopathological features in endometrial
cancer patients. These analyses showed that increased
Piwil1 expression was significantly associated with
FIGO stage (P = 0.042), lymphovascular space involve-
ment (P = 0.000), lymph node metastasis (P = 0.026),
and level of myometrial invasion (P = 0.048), but not
with patient age or histological grade (Table 1).
Overexpression or knockdown of Piwil1 in human
endometrial cancer cell lines
RT-qPCR, western blot and immunofluorescence were
performed to assess the expression of Piwil1 in endo-
metrial cancer cell lines (Additional file 2: Figure S1).
Variable levels of Piwil1 were detected across the endo-
metrial cancer cell lines. Ishikawa (high expression) and
HEC-1B (low expression) cell lines were chosen for fur-
ther experimentation based on their differential expres-
sion of Piwil1.
To determine whether Piwil1 could enhance the
stemness of endometrial cancer cells by inducing
EMT, we transfected Piwil1 expression plasmids into
HEC-1B cell lines to originate Piwil1 overexpression
Fig. 1 Expression of Piwil1 in human endometrial carcinoma tissue. a RT-qPCR analysis for Piwil1 mRNA in normal human endometrial tissues
(n = 10) and endometrial cancer tissues (n = 18) (**P < 0.01). b Representative Piwil1 immunohistochemical staining of normal endometrial tissues,
endometrial atypical hyperplasia and two endometrial cancer types. Original magnification 200×, scale bar, 100 μm (upper); 400×, scale bar,
50 μm (lower). c Immunohistochemistry scores (IS) of Piwil1 in normal endometrium (n = 44), atypical hyperplasia (n = 17), and endometrial
carcinoma tissues (n = 83) (***P < 0.001)
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cells (HEC-1BexPiwil1 cells) and transfected shRNA
against Piwil1 to Ishikawa cell lines to originate
Piwil1 knock-down cells (IshikawashPiwil1 cells). The
transfection efficiency was up to 95 % (Fig. 2a). As
shown in Fig. 2, HEC-1BexPiwil1 cells transfected with
Piwil1 expression plasmids significantly increased
Piwil1 expression in both mRNA and protein levels
compared with HEC-1BEV cell lines (*P < 0.05) and
IshikawashPiwil1 cells transfected with shRNA against
Piwil1 significantly decreased Piwil1 expression in
both mRNA and protein levels compared with the
control cell lines (*P < 0.05).
Piwil1 led to increased acquisition of endometrial cancer
stem cell markers
To evaluate the effect of Piwil1 in the acquisition of
stem-like properties of endometrial cancer cells, we first
studied whether the transfected cells created any shift in
the patterns of expression of endometrial cancer stem
cell markers, such as CD133, CD44 and ALDH1 [7, 22].
RT–qPCR, western blotting and immunofluorescence
confirmed the downregulation of CD44 and ALDH1
in IshikawashPiwil1 cells relative to the control cells
(*P < 0.05, Fig. 3a and c). For the HEC-1BexPiwil1 cells,
we observed increased expression of CD44 and
ALDH1 (*P < 0.05, Fig. 3b and c). There was no sub-
stantial difference in CD133 between transfected cells and
control cells. Furthermore, we also observed decreased ex-
pression of standard stem cell markers, such as Oct4 and
Nanog, in IshikawashPiwil1 cells and increased expression
of Oct4 and Nanog in HEC-1BexPiwil1 cells and (*P < 0.05,
** P < 0.01, Fig. 3a and b).
Piwil1 increased tumor growth potential
Once we had demonstrated that Piwil1 was associated
with the acquisition of stem-like features, we next
considered whether this stem-like phenotype was as-
sociated with particular tumor biology properties. The
most obvious approach was to assess its impact on
tumor growth. We found that IshikawashPiwil1 cells
showed a reduced viability as measured by MTT assay
in comparison with IshikawaNT cells (*P < 0.05, ** P < 0.01,
Fig. 4a) and HEC-1BexPiwil1 cells grew faster than control
cells (** P < 0.01, *** P < 0.001, Fig. 4a). We also performed
colony formation assays to further explore the role of
Piwil1 in cell proliferation. We found more pronounced
and frequent colony formation in IshikawaNT cells than
was found in IshikawashPiwil1 cells (*P < 0.05, Fig. 4b). For
HEC-1BexPiwil1 cells, the ability to form colonies was more
pronounced than HEC-1BEV cells (*P < 0.05, Fig. 4b). The
tumorsphere assay can identify stem-like properties, as it
highlights the cells’ capacity for self-renewal and ability to
form a three-dimensional tumor-like sphere in vitro. The
ability to form spheroid of IshikawaNT cells was more pro-
nounced than IshikawashPiwil1 cells (*P < 0.05, Fig. 4c). We
also found that HEC-1BexPiwil1 cells showed a significant
increase in spheroid formation compared with control
cells (*P < 0.05, Fig. 4c).
Piwil1 enhanced tumor metastatic potential
Increased migration and invasion are another biology
properties of CSCs. To assess whether Piwil1 af-
fected migration and invasion of endometrial cancer
cells, migration or invasion assays were performed.
As indicated in Fig. 5a, migratory ability was signifi-
cantly decreased in IshikawashPiwil1 cells (**P < 0.01),
but enhanced in HEC-1BexPiwil1 cells (**P < 0.01,
Fig. 4d). Consistent with the results of the migration
assay, invasive ability was significantly decreased in
IshikawashPiwil1 cells, but enhanced in HEC-1BexPiwil1
cells (**P < 0.01, Fig. 4d).
Piwil1 led to acquisition of mesenchymal markers and
reduction of epithelial markers
There is a link between EMT and the induction of the
stem cell-like properties of cancer cells in solid tumors.
We then examined the expression of EMT markers in
transfected cells. RT–qPCR and western blotting were
showed that epithelial marker E-cadherin were
Table 1 The correlation of Piwil1 expression with
clinicopathological features in endometrial cancer
Cases (n) Piwil1 IS
Mean ± SD P value
Age
≤55 34 4.9 ± 1.1
>55 49 4.9 ± 1.0 0.9
FIGO stage
I – II 78 4.9 ± 1.0
III - IV 5 6.4 ± 0.9 0.005
Histological grade
G1 - G2 73 4.9 ± 1.1
G3 10 5.5 ± 0.8 0.11
Lymphovascular space involvement
No 68 4.8 ± 1.0
Yes 15 5.9 ± 0.8 0.00
Lymph node metastasis
No 79 4.9 ± 1.1
Yes 4 6.3 ± 1.0 0.03
Myometrial invasion
≤1/2 70 4.9 ± 1.0
>1/2 13 5.7 ± 1.2 0.02
Significance of difference (P value) between categories was analyzed by
Mann–Whitney U test. P < 0.05 for the significance of difference
Chen et al. BMC Cancer  (2015) 15:811 Page 5 of 13
upregulated while the mesenchymal markers Vimentin
and N-cadherin were downregulated in IshikawashPiwil1
cells (*P < 0.05, **P < 0.01, Fig. 5a). For HEC-1BexPiwil1
cells, E-cadherin were downregulated and Vimentin and
N-cadherin were upregulated (*P < 0.05, **P < 0.01, Fig. 5b).
Immunofluorescence staining further confirmed these
results above (Fig. 5c). We also examined whether the ex-
pression of transcription factors which were closely associ-
ated with EMT were changed in transfected cells [23, 24].
Piwil1 could upregulate mRNA expression of Snail
(*P < 0.01), while the mRNA level of Twist was not
significantly changed (Fig. 5a and b).
Fig. 2 Overexpression or knockdown of Piwil1 in human endometrial cancer cell lines. a Stable transfection of Ishikawa cells with shRNA against
Piwil1 and HEC-1B cells with Piwil1 expression plasmids. The percentage of transfected cells with fluorescence was > 95 %. (b and c) RT-qPCR and
western blot demonstrated expression level of Piwil1 in Ishikawa, IshikawaNT and IshikawashPiwil1 cells or HEC-1B, HEC-1BEV and HEC-1BexPiwil1 cells
(*P < 0.05). d Representative immunofluorescence images showing Piwil1 expression in IshikawaNT and IshikawashPiwil1 cells or in HEC-1BEV and
HEC-1BexPiwil1 cells. Nuclei were stained with DAPI. Scale bars, 25 μm
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Fig. 3 (See legend on next page.)
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(See figure on previous page.)
Fig. 3 Piwil1 led to increased acquisition of endometrial cancer stem cell markers. a RT-qPCR and western blot demonstrated expression level of
CD44, ALDH1, CD133, Oct4 and Nanog in IshikawaNT and IshikawashPiwil1 cells (*P < 0.05). b RT-qPCR and western blot demonstrated expression
level of CD44, ALDH1, CD133, Oct4 and Nanog in HEC-1BEV and HEC-1BexPiwil1 cells (*P < 0.05, **P < 0.01). c Representative immunofluorescence
images showing CD44, ALDH1 and CD133 expression in IshikawaNT and IshikawashPiwil1 cells or in HEC-1BEV and HEC-1BexPiwil1 cells. Nuclei were
stained with DAPI. Scale bars, 25 μm
Fig. 4 Piwil1 increased tumor growth potential and enhanced tumor metastatic potential. a The effects of Piwil1 on the cell growth of transfected
cells were determined by MTT assay (*P < 0.05, **P < 0.01, ***P < 0.001). b Plated colony forming assays were performed to measure cell proliferation of
transfected cells. Representative images are shown. The colonies were counted and graphed (*P < 0.05). c Representative images of spheroid colonies
were shown. Scale bars, 100 μm. Quantification of the absolute number of spheroids formed by IshikawashPiwil1 cells or HEC-1BexPiwil1 cells
compared to the control cells after 5 days (*P < 0.05). d Cell migration and invasion was measured in transwell chambers. Quantification
of migration after 24 h and quantification of invasion after 48 h. Data are reported as fold induction vs control cells. Scale bar, 100 μm.
**P < 0.01 Representative images are shown
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Fig. 5 (See legend on next page.)
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Endometrial cancer stem cell markers and EMT-related
markers were detected in tumor-bearing mice
Subcutaneous injection of IshikawaNT and IshikawashPiwil1
cells in immunodeficient mice demonstrated that the tu-
mors generated from the IshikawashPiwil1 cells grew more
slowly than those generated from the same amount of
IshikawaNT cells (** P < 0.01, Fig. 6a). Then the expression
of endometrial cancer cell markers and EMT-related
markers was investigated by immunohistochemistry on
tissues from tumor-bearing mice. Results revealed a sig-
nificantly lower expression of Vimentin, CD44 and
ALDH1 and a higher expression of E-cadherin in tumor
tissues generated from the IshikawashPiwil1 cells compared
with IshikawaNT cells (Fig. 6b).
Discussion
One hypothesis related to carcinogenesis assumes that a
specific population of tumor cells, CSCs, have the ability
to initiate and maintain tumor growth [25]. A increasing
body of evidence suggest that CSCs may originate not
only from somatic stem cells (SSCs) where tumor sup-
pressor genes could be silenced, but also from differenti-
ated cells in which a self-renewal signaling pathway is
activated [2].
(See figure on previous page.)
Fig. 5 Piwil1 led to acquisition of mesenchymal markers and reduction of epithelial markers. a RT-qPCR and western blot demonstrated
expression level of Vimentin, N-cadherin, E-cadherin, Snail and Twist in IshikawaNT and IshikawashPiwil1 cells (*P < 0.05, **P < 0.01). b RT-qPCR and
western blot demonstrated expression level of Vimentin, N-cadherin, E-cadherin, Snail and Twist in HEC-1BexPiwil1 cells and HEC-1BEV cells (*P < 0.05,
**P < 0.01). c Representative images of immunofluorescence staining of EMT markers in IshikawashPiwil1 cells or HEC-1BexPiwil1 cells compared with
control cells. Nuclei were stained with DAPI. Scale bars, 25 μm
Fig. 6 Endometrial cancer stem cell markers and EMT-related markers were detected in tumor-bearing mice. a and b Four weeks after injection
of the indicated cells, tumors were removed and shown. The tumor weights and volumes were determined (*P < 0.05, **P < 0.01). Results represent
tumor growth kinetics were also shown. c Representative Piwil1, E-cadherin, Vimentin, CD44 and ALDH1 immunohistochemical staining in tumor
tissues generated from the IshikawashPiwil1 cells or IshikawaNT cells. Original magnification 400×, scale bar, 50 μm
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Piwi, the other subclade of the Argonaute family, af-
fected asymmetric division of stem cells in the Drosoph-
ila germline [26]. The early studies demonstrated that
Piwi is essential for gametogenesis and is a key regulator
of female germline stem cells [11, 12]. Four Piwi proteins
are expressed in humans: Piwil1/Hiwi, Piwil2/Hili,
Piwil3, and Piwil4/Hiwi2. Most studies showed that Piwi
proteins are overexpressed in human cancers [26]. The
expression of Piwil1, Piwil2, Piwil13, and Piwil4 were
positively correlated with T stage, lymph node metastasis
and clinical TNM and patients with higher expression
had shorter survival time [27, 28]. In this study, we con-
firmed that the expression of Piwi proteins (Piwil1,
Piwil2, Piwil13, and Piwil4) are different in endometrial
cancer cell lines (Additional file 4) and we mainly fo-
cused on the role of Piwil1 in endometrial cancer.
It has been long recognized that the piwil1 is essential
for stem cell self-renewal, division, spermatogenesis,
RNA silencing, and translational regulation in Drosoph-
ila, mice and many other species [11, 29–31]. Piwil1 is
also detected in human CD34+ cells but not in well-
differentiated cells, suggesting it may determine or regu-
late human stem cell development [32]. However, re-
ports focusing on effect of Piwil1 in tumor biology are
limited, and the correlation between Piwil1 and endo-
metrial cancer progression is not well documented.
Here, we showed that Piwil1 was highly expressed in hu-
man endometrial cancer. Specific knockdown or overex-
pression of Piwil1 in endometrial cancer cell lines led to
changes in tumor growth and metastatic potential in
vitro and in vivo. Our results suggest that Piwil1 may be
a part of the molecular pathway necessary for activating
the cell’s capacity for self-renewal in endometrial cancer.
Although several studies have investigated the ex-
pression of Piwil1 in solid cancers, including endo-
metrial cancer, this is the first study to address the
function of Piwil1 in human endometrial cancer. We
found that the normal endometrium produces weak
levels of Piwil1, but that Piwil1 was extensively de-
tected in endometrial cancer, which is in accordance
with reports [14, 33]. Previous studies demonstrate
that high levels of Piwil1 expression could increase
the risk for tumor-related death [17, 18] and may be
a poor prognostic factor for esophageal squamous cell
carcinoma, gastric cancer and hepatocellular carcin-
oma [16, 27, 34]. Consistently, we found a signifi-
cantly positive correlation between Piwil1 expression
and lymphovascular space involvement, lymph node
metastasis, varying depth of myometrial invasion and
advanced disease stage, all of which are associated
with high risk factors in endometrial cancer. Though
these results are not sufficient to definitively designate
Piwil1 as a prognostic factor for endometrial cancer,
our expression data combined with our functional
data suggest that Piwil1 might serve as a target for
anticancer therapy.
To date, CSC markers of endometrial cancer have
been identified, including CD133, CD44 and ALDH1
[7, 22, 35, 36]. Interestingly, we found that overex-
pression of Piwil1 could lead to increased acquisition
of CD44 and ALDH1 and cells with knockdown of
Piwil1 showed decreased expression levels of these
markers. Besides expressing specific markers, CSCs
are defined by their self-renewal capacity, their ability
to generate a new tumor and an increased capacity
for migration and invasion. In our study, we showed
that the ability of proliferation, migration, invasion
and sphere-forming in Ishikawa cells was decreased
by Piwil1 knockdown. Conversely, HEC-1B cells over-
expressing Piwil1 showed increased ability of prolifer-
ation, migration, invasion and sphere-forming. From
our in vivo experiments, we discovered that the
Piwil1 knockdown significantly inhibited the establish-
ment of tumors. Therefore, we for the first time
reported that Piwil1 may regulate stemness of endo-
metrial cancer cells. Ishikawa cell line could be a
useful model to study endometrial CSCs because it
has a higher percentage of CD133+ cells and ability to
undergo differentiation into other lineages [7]. However,
CD133 showed no substantial difference between trans-
fected cells and control cells. These findings raise the pos-
sibility that there are additional candidate genes that
regulated CD133.
During the process of tumor metastasis, preceded by
the EMT [37], metastasized cancer cells appear to require
an ability to self-renew, similar to that seen in stem cells,
to acquire a proliferative potential. In the present study,
we presented several lines of evidence showing that Piwil1
was involved in EMT. We observed that Piwil1 could
downregulate epithelial marker E-cadherin and upregulate
mesenchymal markers Vimentin and N-cadherin in endo-
metrial cancer cells. Snail plays a critical role in EMT [23].
Knock down of Snail could reverse EMT and significantly
attenuated migration, invasion and cancer stem cell-like
properties of cancer cells [38]. We further showed
that Piwil1 could upregulate the transcription of Snail,
indicating that Piwil1 may be required for Snail-
induced EMT. However, further studies are required
to identify the detailed mechanism involved in regula-
tion of Piwil1 on Snail.
Conclusions
In summary, to the best of our knowledge, we are the
first to provide evidence that Piwil1 could induce EMT
and endow endometrial cancer cells with stem-like prop-
erties. Thus, Piwil1 may represent a promising target for
developing a novel treatment strategy for endometrial
cancer.
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